Use of 25-hydroxy-vitamin D3 to affect human muscle physiology

Details for Australian Patent Application No. 2009214054 (hide)

Owner DSM IP Assets B.V.

Inventors Stoecklin, Elisabeth; Claerhout, Wouter; Wolfram, Swen; Leuenberger, Bruno H.; Buck, Neil Robert; Urban, Kai

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009214054

PCT Pub. Number WO2009/101137

Priority 61/028,510 13.02.08 US; 61/031,671 26.02.08 US; 61/036,924 14.03.08 US; 61/129,139 06.06.08 US; 61/036,928 15.03.08 US

Filing date 12 February 2009

Wipo publication date 20 August 2009

International Classifications

A61K 31/593 (2006.01)

A23L 1/303 (2006.01) Foods or foodstuffs

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

Event Publications

2 September 2010 PCT application entered the National Phase

  PCT publication WO2009/101137 Priority application(s): WO2009/101137

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009214062-Moulded connection between cannula and delivery part

2009214053-Treating hyperglycemia with 25-hydroxyvitamin D3